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Abstract In the present study we analyze the oligomeriza-
tion of the 5-HT1A receptor within living cells at the sub-
cellular level. Using a 2-excitation Förster Resonance
Energy Transfer (FRET) method combined with spectral
microscopy we are able to estimate the efficiency of energy
transfer based on donor quenching as well as acceptor
sensitization between CFP-and YFP-tagged 5-HT1A recep-
tors at the plasma membrane. Through the analysis of the
level of apparent FRET efficiency over the various relative
amounts of donor and acceptor, as well as over a range of
total surface expressions of the receptor, we verify the
specific interaction of these receptors. Furthermore we
study the role of acylation in this interaction through
measurements of a palmitoylation-deficient 5-HT1A recep-
tor mutant. Palmitoylation increases the tendency of a
receptor to localize in lipid rich microdomains of the
plasma membrane. This increases the effective surface
density of the receptor and provides for a higher level of
stochastic interaction.
Keywords Palmitoylation.Serotonin.5-HT1Areceptor.
Lipidrafts.FRET.Oligomerization
Abbreviations
GPCR G-protein coupled receptor
EfD Donor dependent apparent FRET efficiency
EfA Acceptor dependent apparent FRET efficiency
xD Donor mole fraction
TD Relative total Concentration
Introduction
G-protein coupled receptors (GPCRs) are a superfamily of
proteins that govern the reactions to a wide range of signals
via activation of the heterotrimeric G-proteins. Structurally,
GPCRs possess seven transmembrane domains linked by
alternating intracellular (i1–i3) and extracellular (e1–e4)
loops. The extracellular receptor surface, including the N-
terminus, is known to be critically involved in ligand
binding. The intracellular receptor surface, including C-
terminal domain and intracellular loops, is known to be
important for G-protein recognition and activation [1].
Members of GPCR family are usually glycosylated and
possess at least one glycosylation site on extracellular N-
terminus. Functionally, N-linked glcosylation of GPCRs
have been shown to be evolved in the regulation of the
receptor’s expression and functions (for review see [2]).
Another common post-translational modification of GPCRs
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Palmitoylation of several GPCRs has been shown to play a
central role in the regulation of the receptor’s functions [4].
Previously, our group has demonstrated that the 5-HT1A
receptor is stably palmitoylated at its C-terminal cysteine
residues Cys417 and Cys420. Furthermore, we have shown
that palmitoylation of 5-HT1A receptor is necessary for Gi-
protein coupling and effector signaling [5].
In recent years there has been a shift in the understand-
ing of distribution of GPCRs in the plasma membrane.
Originally, it was believed that GPCRs existed and
functioned as monomeric units. However, it is now widely
accepted that in many cases oligomerization of these
receptors occurs [6, 7]. Interestingly, receptor oligomeriza-
tion seems to be independent of glycosylation, as has been
shown for human hisamine H(4) and alpha-1b adrenorecep-
tors [8, 9]. In some cases this specific interaction occurs
between the same receptor type (homo-oligomerization)
and in others between different receptors (hetero-
oligomerization). For several GPCRs, oligomerizaiton has
been found to occur early in the receptors lifetime, shortly
after translation. On the other hand, oligomerization has
also been shown to occur at the plasma membrane both in
ligand-dependent and independent manner [10, 11]. Func-
tionally, homo-and hetero-oligomerization have been
found to play an important role in receptor trafficking,
ligand specificity and coupling to specific signaling
pathways [12–17]. Thus, oligomerization may provide an
additional level of control for signal transduction and for
the fine tuning of cellular processes.
Another area of interest in the study of GPCRs is their
lateral distribution within the plasma membrane. Rather
than being uniformly distributed throughout the plasma
membrane, many studies suggest that GPCRs may localize
in cholesterol-rich membrane microdomains or lipid rafts
[18–20]. Many of these reports, often based on biochemical
assay as well as fluorescence techniques, propose that
compartmentalization is necessary for the efficient interac-
tion between signaling partners with low surface concen-
tration. Generally, it has been suggested that lipid rafts may
represent “hot spots” for signaling, working as a platform
for co-localization of GPCRs with corresponding G-
proteins. In addition, it has been proposed that compart-
mentalization in cholesterol rich microdomains occurs due
to hydrophobic mismatch of transmembrane domains as
well as by post-translational acylation of both the receptor
and G-proteins [21–23].
In addition to the role of palmitoylation in the coupling
of the receptor with G-protein [5], we have recently
demonstrated the importance of this modification for the
localization of the 5-HT1A receptor in the lipid rafts [24],
implying that palmitoylation plays a central role in the 5-
HT1A function. We have also recently demonstrated
specific homo-oligomerization of the 5-HT1A receptors
[25]. In this previous investigation we applied both classical
biochemical assays (e.g. co-immunoprecipitation and cross-
linking) as well as biophysical approaches, including
acceptor-photobleaching FRET, time correlated single-
photon counting (TCSPC) FRET, as well as, a novel FRET
approach, lux-FRET, allowing for measurements of the
donor-acceptor ratio and apparent FRET efficiencies from
populations of living cells [26]. In the current study we
applied this method to spectral images acquired using
confocal microscopy, which allows for the investigation of
localization and interaction of 5-HT1A receptors in living
cells with high spatial resolution. Moreover, by defining a
confocal slice which encompasses only the plasma mem-
brane immediately adjacent to the coverslip, we can
measure FRET signal resulting from oligomerization of 5-
HT1A receptors specifically at the membrane without any
contamination from fluorescence from receptors localized
in other intercellular compartments.
Materials and methods
Adherent cell culture and transfection
Mouse N1E-115 neuroblastoma cells from the American
Type Culture collection (ATCC) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS) and 1% penicillin/streptomycin
at 37°C under 5% CO2. For transient transfection, cells
were seeded at low-density in on 35-mm cover-slips and
transfected with vectors encoding CFP-and YFP-tagged
wild-type or acylation-deficient 5-HT1A receptors using
Lipofectemine2000 Reagent (Invitrogen) according to the
manufacture’s instruction. Four hours after transfection,
cells were serum starved overnight before analysis.
Live cell confocal microscopy and spectral imaging
Coverslips with N1E-115 cells co-expressing 5-HT1A-CFP
and 5-HT1A-YFP fusion proteins were placed in a custom
made image acquisition chamber in 2 ml of D-PBS at room
temperature. Images were acquired with an LSM 510-Meta
confocal microscope (Carl Zeiss Jena) using a 40×/1.3 NA
oil-immersion objective with a pixel count of 256×256, a
pixel dwell time of 1.92 μs, and 4× frame averaging,
resulting in a total image acquisition time of approximately
1 s. The 458 and 488 nm lines of a 40 mWargon laser were
used for the two excitation FRET method as described in
[26]. Fluorescence emission was collected in eight channels
of the Zeiss Meta detector at 21.4 nm steps. All images
were digitized/collected with 12 bit resolution.
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Prior to FRET analysis, images collected at two excitation
wavelengths were spatially aligned with respect to each
other, in order to eliminate artifacts resulting from mis-
alignment. Image registration usually required less than a
2 pixel shift in the x–y plane. Next the spectral data from
each pixel of the two images were analyzed according to
the method described by Wlodarczyk et al.[ 26]. Briefly, for
each pixel of the spectral images of the FRET samples,
linear unmixing was performed using CFP, YFP and
background reference spectra to separate the respective
contributions of these species to total fluorescence. Using
the apparent concentration of the donor and acceptor
fluorophores along with calibration information about the
relative level of excitation of our donor and acceptor at the
two different wavelengths, we are able to calculate donor
apparent FRET efficiency, EfD, acceptor apparent FRET
efficiency, EfA, the FRET corrected acceptor to donor ratio
and FRET corrected total concentration with respect to
either reference measurement. All images and procedures
were analyzed using Matlab 7.2 (The MathWorks, Natick,
MA, USA).
Model of FRET in oligomers
A model characterizing apparent FRET efficiency, EfD,a sa
function of donor mole fraction, xD, for oligomeric
structures has been developed previously [27],
EfD ¼ E 1   xn 1
d

: ð1Þ
Fitting this model to experimental data allows for the
estimation of the true transfer efficiency, E, and also
provides information about the number of units, n,
interacting in the oligomeric complex. Recently, this model
has been slightly augmented for use with EfA, [28],
EfA ¼ E
xd
1   xd
1   xn 1
d

: ð2Þ
Results and discussion
Measurements of FRET signal from the plasma membrane
of living cells
We have recently verified the oligomerization state of the 5-
HT1A receptor by using a co-immunoprecipitation and
cross-linker assays performed in neuroblastoma N1E-115
cells [25]. These biochemical methods represent the
classical approaches used for the detection of GPCR
oligomerization. However, these methods often result in
artificial aggregation of receptors and do not allow for the
analysis of GPCR oligomerization in living cells [29]. To
overcome these limitations, we have implemented a novel
lux-FRET approach allowing for oligomerization analysis
in living cells [26]. Despite the advantages of this method,
it has only been applied to the populations of cells and
therefore has not allowed for the differentiation between
receptors localized at the plasma membrane and those
residing in the endoplasmic reticulum, Golgi network or in
transport vesicles.
In the present study we are primarily interested in the
oligomerization of 5-HT1A receptors at the plasma mem-
brane due to its possible influence on ligand binding and
selectivity, G-protein coupling and activation, and receptor
internalization. For these reasons it is important to verify
receptor oligomerization specifically at the plasma mem-
brane and exclude artifacts from interaction in other
intercellular compartments. Therefore, we adapted the lux-
FRET approach to the application at confocal microscopy,
allowing for the analysis of receptor oligomerization with
sub-cellular resolution. Figure 1A shows the 3-D recon-
struction of a series of confocal slices through an N1E-115
cell co-expressing 5-HT1A-CFP and 5-HT1A-YFP receptor
constructs at a 1:1 ratio. The center panel shows the
confocal slice where fluorescence was detected specifically
at the plasma membrane immediately adjacent to the
coverslip on which the cell is growing. In addition to the
clear membrane localization of the fluorescently-tagged
receptors, some intercellular fluorescence is also detectable
(particularly apparent in the y-z section). In the following
FRET measurements similar confocal slices were used for
analysis. To avoid artefacts resulting from overexpression,
we adjusted the total expression level for the CFP-and YFP-
tagged receptor to 1.000–1.200 fmol/mg proteins in all
following FRET experiments, which allows for quantitative
analysis of results obtained in different experiments [25].
Moreover, similar amounts of endogenous 5-HT1A recep-
tors has been obtained in hippocampus under physiological
conditions [30, 31].The lux-FRET method implemented in
this investigation requires the acquisition of fluorescent
emission spectra resulting from two separate excitation
wavelengths. To apply this method to microscopy, two
images were acquired, one with excitation using the 458 nm
laser line, the other with excitation at 488 nm. Fluorescence
emission was collected simultaneously over eight channels
for each acquisition, allowing for reconstruction of emis-
sion spectra on a per pixel basis. Figure 1B shows the
measured emission intensities of a single pixel over the
eight channels used in the image acquisition for a cell co-
expressing 5-HT1A-CFP and 5-HT1A-YFP. This figure
also shows the weighted contributions of CFP, YFP and
background signal which combine to provide a fit to the
acquired fluorescent spectra of the FRET sample. Using the
per pixel weights of CFP and YFP from the fitting of two
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define donor-and acceptor-based apparent FRET efficien-
cies (EfD and EfA), a FRET-corrected donor molar fraction
(xD) , as well as a FRET-corrected total receptor concen-
tration (TD) for each pixel of the image. This allows us to
not only quantify apparent FRET as a function of donor/
acceptor ratio, but also to investigate the effect of local
concentration differences on oligomerization specificity at
the single-cell level. It is also notable, that although the
GFP-variants used in this study do not have the monomeric
mutation, this does not result in artificial FRET signal. We
have previously investigated FRET resulting from the
assumed spontaneous aggregation of the cytosolic non-
monomeric CFP and YFP coexpressed in neuroblastoma
N1E-115 cells [26]. In this study we reported that the level
of FRET in control measurements showed a strong
dependence on concentration, with the maximum EfD value
of 0.05 only occurring at a much higher concentration than
was used in the current investigation.
Oligomerization of the 5-HT1A receptor in the plasma
membrane is independent of its palmitoylation state
The apparent FRET efficiencies, EfD and EfA,m e a s u r e d
by the lux-FRET technique are estimates for the true
energy transfer efficiency that are scaled by donor or
acceptor fractional labeling. The fractional labeling terms,
fD and fA, are defined as the concentration of donor and
acceptor in the FRET complexes, [DA], divided by total
respective fluorophore concentration, [D
t]a n d[ A
t]. The
fractional labeling terms are inherently dependent on the
acceptor to donor ratio. Based on this dependency, a model
has been previously developed allowing for the estimation of
the true energy transfer efficiency as well as the number of
units interacting in an oligomeric complex [27, 28]. This
model can correctly identify case of dimerization (n=2) and,
although it cannot accurately quantify the number of units
reacting if above two, it still can be used to identify such
cases.
Application of this model requires not only the measure-
ment of apparent FRETefficiency, but also of an acceptor to
donor ratio that is corrected for donor quenching as well as
for acceptor sensitization. The lux-FRET provides these
values and allows us to correctly apply this model to
characterize the homo-oligomerization between wild-type
and acylation-deficient 5-HT1A receptors. To acquire the
data required to implement this model, cells grown on
coverslips were co-transfected with different amounts of
CFP-and YFP-tagged receptors. It is noteworthy that the
total DNA concentration used for each transfection was held
constant, while the ratios between donor (CFP-tagged
receptors) and acceptor (YFP-tagged receptor) was varied
between 1:7 and 7:1. In the image acquisition for FRET
measurements, the confocal plane was adjusted so that only
fluorescence from proteins localized in the plasma mem-
brane immediately adjacent to the coverslip was collected.
Initial images were acquired with the 458 nm laser line and
immediately followed by acquisitions with the 488 nm laser
line. Finally, FRET calculations were performed on a per
pixel basis as described in the “Materials and methods”
section. For the determination of the relationship between
apparent FRET efficiency and acceptor to donor ratio, 115
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Fig 1 Overview of the method used to measure FRET selectively at
the plasma membrane. (A) A series of z-stacks were acquired for a cell
co-expressing YFP-tagged 5-HT1A receptor. Three-dimensional re-
construction and orthogonal plane analysis shows the receptor
distribution in the x, y and z plane. The images show localization of
the receptors in the plasma membrane as well as minor florescence
from intercellular structures (most prominent in the y–z plane) that can
lead to incorrect characterization of FRET in whole cell measure-
ments. The cyan lines shown in both the x–z and y–z planes represent
the confocal depth of the x-y image which is representative of those
acquired for FRET analysis. Scale bar represents 20 μm. (B)
Simultaneous acquisition of fluorescence emission in eight channels
allows for the reconstruction of per pixel fluorescence emission
spectra of a FRET sample co-expressing 5-HT1A-CFP and 5-HT1A-
YFP receptors, designated as ‘IM’. Linear unmixing allows us to
determine the weighted contributions from CFP, YFP and the
background signal that combine to fit the measured spectra,
designated as ‘CFP’, ‘YFP’, ‘BG’, and ‘Fit’, respectively. The weights
of the donor and acceptor spectra that provide the best fit, along with
calibration parameters, are used in the analysis of FRET
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Fig 2 Oligomerization of the
wild-type 5-HT1A receptor
measured by lux-FRET. (A)
Application of the two excita-
tion FRET method described in
“Materials and methods” and
outlined in Fig. 1, allows us to
create images of EfD, EfA, xD,a s
well as FRET corrected total
concentration TD.( B) Mean
values of 10×10 μm regions of
interest from cells expressing
different ratios of 5-HT1A-CFP
and 5-HT1A-YFP receptors
allows to characterize the ap-
parent FRET efficiency over the
donor mole fraction. The data
were collected from 115 cells
and binned along donor mole
fraction in 0.05 increments. Data
points represent the mean ±SD
of the apparent FRET efficiency
values from each bin. The fits to
the data are based on the models
described in Eqs. 1 and 2. The
fitted parameters from the EfD
model were found to be E=0.11
and n=2.96 (R
2=0.69) and from
the EfA model, E=0.16 n=2.44
(R
2=0.83). (C) To address the
effect of surface concentration
on measured FRET a measured
EfA is shown plotted as a func-
tion of corresponding relative
total concentration TD. The plot
shows that EfA is fairly inde-
pendent from the total concen-
tration at the region of
membrane at which it was mea-
sured. The data points shown
represent mean ±SE of EfA
values separated by
corresponding TD value into 15
bins. The relative total surface
concentration, TD, was calculat-
ed by the lux-FRET method and
corrected for both donor
quenching and acceptor sensiti-
zation (independent of FRET)
and is given in units of donor
reference concentration
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Fig 3 Oligomeriztion of the
palmitoylation-deficient 5-
HT1A receptor measured by
lux-FRET. (A) lux-FRET
images of N1E-115 cells
expressing palmitoylation-
deficient mutant receptors show
that the membrane distribution
of the calculated values appear
no different than for the wild-
type receptors shown in Fig. 2A.
(B) The characterization of
FRET as a function of donor
mole fraction further shows that
there is little difference between
the interaction of the wild type
receptors and the interaction of
the mutant receptors. Applica-
tion of the previously mentioned
models suggests that for the EfD
data E=0.21 and n=1.70 (R
2=
0.86) and for the EfA data E=
0.17 and n=2.10 (R
2=0.89). (C)
Similarly to the wild-type re-
ceptor, plotting EfA values
against spatially corresponding
concentration values shows that
there is no dependence of
measured FRET on surface
concentration of the
palmitoylation-deficient 5-
HT1A receptor
754 Glycoconj J (2009) 26:749–756cells were measured for both wild-type and mutant
receptors. Results obtained with a donor mole fraction
below 0.2 and above 0.8 were excluded from the analysis
due to error resulting from excessive differential bleaching
between CFP and YFP.
Figure 2A shows the spatial distribution of the apparent
FRETefficiencies (EfD and EfA), the donor mole fraction, as
well as the relative total concentration at the plasma
membrane of the cell co-transfected with the CFP-and
YFP-tagged wild-type receptors. Based on these results we
were able to build the relationship between the apparent
FRETefficiencies and the donor mole fraction, xD. Analysis
of the data according to the aforementioned model reveals
that the best fit for the EfD data was achieved with values of
E=0.11 and n=2.95 (R
2=0.69). The best fit for the EfA data
was achieved with E=0.16 and n=2.44 (R
2=0.83). Taken
together these data suggest that in the case of the wild-type
5-HT1A receptor, more than two units participate in the
formation of oligomers. However, due to the limitations of
the model, we cannot exactly define the n-value.
To analyze the role of receptor palmitoylation for the
oligomerization at the plasma membrane, we performed
similar single-cell FRET analysis for the cells expressing
CFP-and YFP-tagged acylation-deficient mutants (Fig. 3A).
Comparison of the panel A in Figs. 2 and 3 does not reveal
any significant differences in receptor or FRET distribution
at the plasma membrane between wild-type and mutated
receptors. These figures also demonstrate that the overall
levels of the FRET for the cases of wild-type and non-
palmitoylated receptor expression were comparable. How-
ever, we obtained a slight difference in the relationship of
FRET to the donor mole fraction. In the case of the mutant
receptor, the limiting value of EfD approaches the same
value as EfA, while with the wild-type receptor the limit of
the EfA value was greater than that of the EfD. Fitting the
data according to the oligomerization model for the EfD
produced the value of E=0.21 and n=1.70 (R
2=0.8641)
and for EfA-values of E=0.17 and n=2.10 (R
2=0.8874) for
the non-palmitoylated receptors.
It is also notable that the goodness of fit of the model
to the wild-type receptor data is lower than to the mutant
receptor data. The previously mentioned deficiency in the
model may result in a less than ideal fit for data measured
from a system with complexes composed of more than
two units, as is the suggested case for the wild-type
receptor.
Differences between the E values obtained for wild-type
and mutated receptors suggest that non-palmitoylated
receptor possesses a higher characteristic efficiency of
energy transfer or a higher percentage of receptors are
involved in oligomerization. Palmitoylation of the 5-HT1A
receptor has been suggested to be responsible for the
creation of an additional fourth intracellular loop at the
receptor C-terminus [5]. The non-palmitoylated mutant will
lack this loop and, therefore, may adopt a conformation
which is more favorable for the FRET between the C-
terminally fused fluorophores.
In the case of the acylation-deficient mutant, the
oligomeric complexes were suggested to be formed by
two interacting units (n=1.7 and n=2.10, for the EfD and
EfA fits, respectively), while in the wild-type receptor more
than two units can be involved in complex formation (n=
2.95 and n=2.44, for the EfD and EfA fits, respectively).
One possible explanation for such differences is the
differential distribution of wild-type and mutant receptors
within the plasma membrane. We have previously demon-
strated that significant fraction of the 5-HT1A receptor
resides in lipid rafts, while the yield of the palmitoylation-
deficient receptor in these membrane microdomains is
considerably reduced [24]. Furthermore, it has been shown
that localization of proteins in lipid rafts may significantly
increase stochastic interaction [28]. Therefore, the sug-
gested greater number of units participating in complex
obtained from the model for the wild-type receptors may
results from stochastic interaction between oligomeric
complexes with free receptors and/or with another com-
plex localized in lipid microdomain. In contrast, non-
palmitoylated receptors, which are excluded from lipid
rafts [24], have a much lower probability for the additional
interaction.
The next important question addressed in the present
study was the analysis of interaction specificity. It has been
reported that positive FRET signals may result not only
from specific protein interactions, including receptor olig-
omerization, but also from randomly distributed and over-
expressed FRET donors and acceptors. Based on the critical
analysis of BRET data, it has been recently considered that
the contribution of non-specific interactions measured by
resonance energy transfer may be even larger than
previously thought [32]. Interaction specificity may be
analyzed by plotting energy transfer efficiency as a function
of expression level at fixed donor/acceptor ratio [32]. In the
case of random interaction it has been proposed that the
energy transfer between two fluorophores is linearly
dependent on expression level and will diminish to zero at
very low concentration of fluorophores. In the case of non-
random interaction, the apparent FRET efficiency should be
relatively independent of concentration with an EfA inter-
cept greater than zero. Figures 2Ca n d3Cs h o wt h e
relationship between apparent FRET efficiency EfA and
total surface concentration TD obtained for the wild-type
and acylation-deficient receptors at fixed donor to acceptor
ratio. Both Figs. 2Ca n d3C demonstrate that FRET
obtained for 5-HT1A receptors was largely independent of
expression level, confirming non-random interactions be-
tween the receptors.
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